BrainCheck Raises $10M in Series B Funding

November 3, 2021 / Nueterra Capital Marketing

BrainCheck | A Nueterra Capital Portfolio Company

Nueterra Capital portfolio company BrainCheck has raised $10 million in Series B funding, the company announced in a press release. Nueterra Capital participated in the Series B round, which takes the total capital raised by BrainCheck to date to $20 million. BrainCheck’s cognitive healthcare platform allows physicians to facilitate in-person or remote cognitive testing via a 10-15 minute test that’s covered by Medicare and most insurers. As reported in TechCrunch, BrainCheck will use the Series B funding to expand its research and development and go-to-market capabilities as it pursues new digital therapeutics for Alzheimer’s and related dementias.